ASP Isotopes
ASPI
ASP Isotopes Inc. (NASDAQ: ASPI) develops isotope enrichment for nuclear fuel and medical applications.
ASP employs laser and quantum enrichment for HALEU and Li-6 production, targeting TRISO fuel supply chains. Its facilities in South Africa support U.S. advanced reactor demos. The company secured DOE grants for HALEU in 2024.
Why it matters now
ASP addresses 2025-2026 HALEU bottlenecks critical for SMR deployments, enabling fuel for Natrium and Hermes pilots.
Related stocks
ASPI